T cells as therapeutic targets in SLE. - Wikidata - awgldk - TriplyDB

T cells as therapeutic targets in SLE.

T cells as therapeutic targets in SLE.

http://www.wikidata.org/entity/Q34075552

about

Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus Neutrophils in the pathogenesis and manifestations of SLE Small molecules in the treatment of systemic lupus erythematosus Targeting dendritic cell function during systemic autoimmunity to restore tolerance Birdshot retinochoroidopathy miRNAs in the Pathogenesis of Systemic Lupus Erythematosus An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck The pathogenesis of systemic lupus erythematosus—an update FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.T/B-cell interactions are more transient in response to weak stimuli in SLE-prone mice.A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus.A novel isoform of the Ly108 gene ameliorates murine lupus.Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.T cell activation by terminal complex of complement and immune complexes.Interleukin (IL)-21 promotes intestinal IgA response to microbiota.The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice Association of mtDNA M/N haplogroups with systemic lupus erythematosus: a case-control study of Han Chinese women.TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus.Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Down Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor γ.Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.HDAC expression and activity is upregulated in diseased lupus-prone mice.Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity.Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Nanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype.CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus

P2860

Q26773124-8957355D-AE93-47E7-891A-569595E352B0 Q27000384-C5F20A86-96DB-4A17-8410-7E7A8D7345D4 Q27010090-A191E19C-4315-45AB-88D7-0E9407281ED8 Q27687098-7934389B-ADA4-4EDD-A09D-6A722B67D3AD Q28080595-179BF990-5416-4DEB-84BB-EC94DB1229D6 Q28083028-8DD637AC-3CFB-4F66-8BA7-F10D3E5FF0A0 Q28085576-B90A0EFD-4A67-40D2-8348-5FCA62E71B41 Q28395086-4A7D8608-86BD-45A5-B37D-7C6A3E88BBF7 Q28591171-13A4302F-9A41-4A9F-807D-F56885B6B20E Q29394347-4B8A222F-9032-4B58-B914-5C006C785E22 Q30698666-C0D857C8-9013-4C2B-A38E-39ECBA7A40C2 Q33555406-BA5932D7-935E-4894-871F-7CE5B08D3A28 Q33577386-854DC236-D984-4092-8526-C8222512BA4E Q34184574-FCFFDA4D-EA27-4F4A-B61C-7EF55DC8F9AF Q34284885-A5178023-FEEE-4AC0-9FDF-180B34D5BD05 Q34614005-8FC710D9-B36E-49AE-8C64-704B669867E1 Q34663968-A108A360-9A62-497E-8DAC-51FA5504C289 Q35023185-82DFBE59-97E8-4A9B-AD3A-43E6E5A27D3D Q35102250-63F2007A-EB65-457A-A7BC-57AB3D91B990 Q35184749-85E0D42D-DF49-4052-B327-58EAFB329AD1 Q35345025-4FF2C8B4-2A6B-455B-BEA2-FB3A8FE63E25 Q35515678-1EBCC34A-3A76-4322-97A4-760046A6FF80 Q35542428-41A9877F-D007-4F7B-A93A-B5A126B6F494 Q35606420-177FD4F9-7753-4C4E-BFF8-3369FE05AD3B Q35673271-87C24655-7D1F-4049-BD41-9E92F7CE8C5B Q35678855-EB7F0592-3E6B-4738-9557-7C561B9B4D0F Q35795451-6FED20EC-2AEF-442A-803E-1C57BC249E1D Q35919031-C19252C3-4A3C-4DD8-A5EA-48E704E6A85C Q36075382-2ACE450F-C3AF-40B8-B0F7-D83DE6786C7D Q36084002-69696E0B-895C-4CFC-8F6E-4965DB18B024 Q36118295-E080D1B8-F17D-43CC-9BB3-07DFEA536CA3 Q36338516-1CF60938-EAFC-46EF-96B6-AD28970DB6C2 Q36342930-26EF6A95-5F78-44CB-B468-A61625FB6F52 Q36355671-38053994-1903-4E5E-B3EB-E41D2F44A7D5 Q36566751-D7ED7AE9-BE1C-4AD0-813D-11F30C1859F2 Q36574781-CF44EAD4-84E5-4330-8FF8-FE4FAA6E35F5 Q36712941-2594FB6B-C0EF-4ECC-8EDA-0D8D5EC5481E Q36794555-79ADE542-C8E6-4DF5-8348-31E0E91BE65A Q36903043-45B9EDE6-84D2-47B8-A969-CC006D291A1D Q36966870-5D268BD5-C519-4AF1-B05F-50EC351918F1

P2860

T cells as therapeutic targets in SLE.

http://www.wikidata.org/entity/Q34075552

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

T cells as therapeutic targets in SLE.

@ast

T cells as therapeutic targets in SLE.

@en

T cells as therapeutic targets in SLE.

@nl

type

label

T cells as therapeutic targets in SLE.

@ast

T cells as therapeutic targets in SLE.

@en

T cells as therapeutic targets in SLE.

@nl

prefLabel

T cells as therapeutic targets in SLE.

@ast

T cells as therapeutic targets in SLE.

@en

T cells as therapeutic targets in SLE.

@nl

P1433

Q34075552-3E0F9F1E-A112-4F5A-9944-C84DA4DFC734

P1476

Q34075552-8AF3F66A-3C60-492B-9463-C7F11B9860E0

P2093

Q34075552-06A8FDE4-71BE-408C-B3EE-2C7AF90F8CFA

Q34075552-1A4A4E9E-B57C-4CE6-8022-C63387D885BD

Q34075552-CC3E9347-49E9-4CF1-8928-E69E53709F1C

Q34075552-F85E62A8-6BEA-47F7-AEC0-93100844657C

P2860

Q34075552-029371E0-022A-4412-9B3F-74331F5A1B47

Q34075552-041FDD34-7678-41C5-A9D2-93C05A2FD0D6

Q34075552-063E234F-59ED-444A-8E36-1B1F41A63391

Q34075552-06CF86A6-9777-424A-95EC-C7955BEE9B29

Q34075552-0C6FC64F-D9F9-4C0D-A61B-0DFF14A1D0F9

Q34075552-100309DA-4CC7-4D1E-8C4C-3176E0B5A82D

Q34075552-1437EE74-8D4C-4AC4-9B6F-0FF2FD533A46

Q34075552-19BEFBDD-BDF5-4BD4-BF69-C14022492ED2

Q34075552-1FB2CBBB-B438-46F7-8502-4B9AE09D7A84

Q34075552-207BA012-81A6-486C-8AA8-7189C15DF0CA

P2888

Q34075552-D490CC99-C1D5-4D2A-AFB7-12BA2FCDBF13

P304

Q34075552-65C3E859-5F80-4962-B251-E5D9396435F2

P31

Q34075552-62D2F32A-5CEC-4FF8-80E0-6035321C66CA

P356

Q34075552-A989180B-1FD5-4B13-A4EA-7FC5EAAF3128

P407

Q34075552-AAD52841-1FA2-4260-B466-D4AFEC414C73

P433

Q34075552-10836C76-586A-4F78-8207-F2C8132C2786

P478

Q34075552-290A3C77-E96F-4050-964E-AF4089B18933

P577

Q34075552-4CBC1A65-D9D4-4A60-88AB-E99A4D43708F

P5875

Q34075552-0CEE7C0F-4F84-4B7B-815C-10FBAC690BB8

P6179

Q34075552-495FEDFB-700A-4A0A-A991-15093841C35E

P698

Q34075552-1124D927-6DAF-4AF1-86A4-AB2B1CE0CCB9

P932

Q34075552-190E0216-8F14-4144-BF1B-2FE44CF17F8C

P356

NRRHEUM.2010.60

P1433

Nature Reviews Rheumatology

P1476

T cells as therapeutic targets in SLE.

@en

P2093

Cox Terhorst

http://www.w3.org/2001/XMLSchema#string

George C Tsokos

http://www.w3.org/2001/XMLSchema#string

José C Crispín

http://www.w3.org/2001/XMLSchema#string

Vasileios C Kyttaris

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci

IL-17 and Th17 Cells

Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis

Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX

Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis.

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.

T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus.

P2888

nrrheum.2010.60

P304

317-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2010.60

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44588146

http://www.w3.org/2001/XMLSchema#string

P6179

1034812369

http://www.w3.org/2001/XMLSchema#string

P698

20458333

http://www.w3.org/2001/XMLSchema#string

P932

2924434

http://www.w3.org/2001/XMLSchema#string